Searched for
AGILA SPECIALITIES
Insulated from Mylan notice, there will be no financial impact: Drug maker Strides ShasunThere has not been any new occurrence of which a notice has been received from Mylan in relation to the USFDA, Strides told the stock excha...- Strides invests in US-based biosimilar companyStrides Arcolab has invested in Oncobiologics Inc, a privately held US-based drug company focussed on biosimilar and novel biologic drug re...
- Goldman Sachs sells 4.2 lakh Strides shares for Rs 36.8 croreGoldman Sachs Investments Mauritius, a shareholder of Strides Arcolab, today sold 4.2 lakh shares of the drug company for Rs 36.81 crore in...
- Strides to pay dividend of Rs 500 per share post Agila saleArcolab said it will pay a special dividend of Rs 500 per equity share following the completion of its sale of Agila Specialties division t...
- Strides Arcolab Q3 net profit slumps 93 pc to Rs 2 croreDrug firm Strides Arcolab today reported 92.65 per cent decline in net profit at Rs 2.21 crore for the quarter ended September 30.
- FIPB clears Mylan's acquisition of Strides Arcolab subsidiary Agila SpecialitiesThe board also cleared 15 foreign direct investment (FDI) proposal worth Rs 2,000 crore, the finance minister said in a statement on Friday.
- Govt clears 15 FDI proposals worth Rs 2,000.5 croreThe Finance Ministry today said it has approved 15 foreign investment proposals totalling Rs 2,000.5 crore and recommended two FDI applicat...
- Strides Arcolab to reward shareholders with up to Rs 800/share payout post Agila saleStrides will be returning cash to investors after the crash in rupee bumped up the money it is getting for selling its Agila unit to Mylan ...
- Govt clears Mylan's Rs 5,168-cr deal to acquire Agila SpecialtiesThe decision was taken at a meeting of the Cabinet Committee of Economic Affairs held, Information and Broadcasting Minister Manish Tiwari ...
- Strides Arcolab surges over 7 pc as FIPB clears Mylan's FDI proposalSince Mylan's investment proposal is of over Rs 1,200 crore, it will go to the Cabinet Committee on Economic Affairs for final approval.
- FIPB clears US pharma major Mylan's Rs 5,168 crore FDI proposalUS-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...
- Strides Arcolab scrip falls 12 per cent after getting a '483' letter from USFDAThe company has received a '483' missive because gloves were reused in the sterile injectables area, and the matter might be resolved soon.
- Agila acquisition to help Mylan become global player in injectables: Rajiv MalikThis unique asset will help us significantly expand and diversify our product portfolio and geographic reach, strengthen our presence in th...
- Strides Arcolab sells Agila Specialities to Mylan for $1600Pharmaceutical company Strides Arcolab will sell its specialities division, Agila Specialities to Mylan for $1600 million in cash and a pot...
- Strides plunges 12.5% as unit sale to Pfizer seen hitting valuation hurdleShares of mid-cap pharma company Strides Arcolab plunged as much as 17.5% on Thursday on speculation that a potential sale of its injectabl...
- Strides Arcolab hits 52-week high on US FDA approval for Ifosfamide injectionStrides Arcolab Ltd surged over 2 per cent in trade on Thursday after Onco Therapies received ANDA approval for Ifosfamide Injection.
- Strides Acrolab buys injectable facility for Rs 125 croreStrides Arcolab's wholly-owned subsidiary Agila Specialities acquired Sterile Formulations facility located at Hosur from Star Drugs and Re...
- Strides Arcolab buys injectable facility for Rs 125 croreThe buy will give the Bangalore-based firm market advantage to set up and commercialise a Greenfield project that can take anywhere between...
- Strides Arcolab gets USFDA nod for Bangalore unit's productDrug firm Strides Arcolab today said it has received US health regulator's approval to market a product from its new facility in Karnataka.
- Strides rebrands Stride Specialties as Agila SpecialtiesDrug firm Strides Arcolab today said it has rebranded its specialities division, Strides Specialties as Agila Specialties, and that it will...
Load More
